Tsung-Ming Shih

Dr. Tsung-Ming Shih

U. S. Army Medical Research Institute of Chemical Defense
orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 April 2016 in Annals of the New York Academy of Sciences
Verified
Journal Article
Closed access
PDF file
JKJeffrey A. Koenig
Jeffrey A. Koenig
TDThuy L. Dao
Thuy L. Dao
RKRobert K. Kan
Robert K. Kan
TSTsung-Ming Shih
Tsung-Ming Shih

7 June 2016 in Toxicology Mechanisms and Methods
Verified
Journal Article
Closed access
CACindy Acon-Chen
Cindy Acon-Chen
JKJeffrey A. Koenig
Jeffrey A. Koenig
GSGarrett R. Smith
Garrett R. Smith
ATAmber R. Truitt
Amber R. Truitt
TTThaddeus P. Thomas
Thaddeus P. Thomas
TSTsung-Ming Shih
Tsung-Ming Shih
Organophosphorus nerve agents such as soman (GD) inhibit acetylcholinesterase, producing an excess of acetylcholine (ACh), which results in respiratory distress, convulsions and status epilepticus that leads to neuropathology. Several drugs (topiramate, clobazam, pregnanolone, allopregnanolone, UBP 302, cyclopentyladenosine [CPA], ketamine, midazolam and scopolamine) have been identified as potential neuroprotectants that may terminate seizures and reduce brain damage. To systematically evaluate their efficacy, this study employed in vivo striatal microdialysis and liquid chromatography to respectively collect and analyze extracellular ACh in freely moving rats treated with these drugs 20 min after seizure onset induced by a high dose of GD. Along with microdialysis, EEG activity was recorded and neuropathology assessed at 24 h. GD induced a marked increase of ACh, which peaked at 30 min post-exposure to 800% of control levels and then steadily decreased toward baseline levels. Approximately 40 min after treatment, only midazolam (10 mg/kg) and CPA (60 mg/kg) caused a significant reduction of ACh levels, with CPA reducing ACh levels more rapidly than midazolam. Both drugs facilitated a return to baseline levels at least 55 min after treatment. At 24 h, only animals treated with CPA (67%), midazolam (18%) and scopolamine (27%) exhibited seizure termination. While all treatments except for topiramate reduced neuropathology, CPA, midazolam and scopolamine showed the greatest reduction in pathology. Our results suggest that delayed treatment with CPA, midazolam, or scopolamine is effective at reducing GD-induced seizure activity and neuropathology, with CPA and midazolam capable of facilitating a reduction in GD-induced ACh elevation.

22 May 2014 in Toxicology Mechanisms and Methods
Verified
Journal Article
Closed access
PDF file
TTThaddeus P. Thomas
Thaddeus P. Thomas
TSTsung-Ming Shih
Tsung-Ming Shih
The current regimen for treating nerve agent poisoning does not sufficiently suppress the excitotoxic activity that causes severe brain damage, especially in cases where treatment is delayed and nerve agent-induced status epilepticus develops. New therapeutic targets are required to improve survivability and minimize neuropathology after irreversible acetylcholinesterase inactivation. Earlier studies have shown that systemic delivery of adenosine agonists decreases nerve agent lethality; however, the mechanism of protection remains to be understood. The primary aim of this study was to investigate the role of central adenosine receptor (AR) stimulation in neuroprotection by directly injecting (6)-cyclopentyladenosine (CPA), an adenosine agonist specific to the A1 receptor subtype (A1R), into the brain intracerebroventricularly (ICV) in a soman seizure rat model. In addition to general A1R stimulation, we hypothesized that bilateral micro-injection of CPA into the cholinergic basal forebrain (BF) could also suppress excitotoxic activity. The results from these studies demonstrated that centrally administered adenosine agonists are anti-seizure and neuroprotective. CPA-delivered ICV prevented seizure and convulsion in 100% of the animals. Moreover, neuropathological evaluation indicated that adenosine treatments reduced brain damage from severe to minimal. Inhibition of the BF via CPA had varied results. Some animals were protected by treatment; however, others displayed similar pathology to the control. Overall, these data suggest that stimulating central ARs could be an effective target for the next generation countermeasures for nerve agent intoxication.

17 November 2020 in Toxics
Verified
Journal Article
Open access
PDF file
JKJeffrey A. Koenig
Jeffrey A. Koenig
CCCindy Acon Chen
Cindy Acon Chen
TSTsung-Ming Shih
Tsung-Ming Shih
Organophosphorus compound exposure remains a present threat through agricultural accidents, warfare, or terrorist activity. The primary mechanism of organophosphorus toxicity is through inhibition of the enzyme acetylcholinesterase, with current emergency treatment including anticholinergics, benzodiazepines, and oxime reactivators. However, a need for more effective and broadly acting countermeasures remains. This study aimed to develop larval zebrafish as a high-throughput model for evaluating novel therapeutics against acute organophosphorus exposure. Larval zebrafish at six days post-fertilization were exposed to acute concentrations of seven organophosphorus compounds and treated with one of three oximes. Lethality studies indicated similar relative toxicity to that seen in the established rodent model, with chemical warfare agents proving more lethal than organophosphorus pesticides. Additionally, the organophosphorus-specific response for oxime reactivation of acetylcholinesterase was comparable to what has been previously reported. Behavioral studies measuring the visual motor response demonstrated greater efficacy for centrally acting oxime compounds than for those that are contained to the peripheral tissue. Overall, these results support the use of this larval zebrafish model as a high-throughput screening platform for evaluating novel treatments following acute organophosphorus exposure.

1 April 2021 in Toxicology and Applied Pharmacology
Verified
Journal Article
Closed access
KMKristy L. Meads
Kristy L. Meads
TTThaddeus P. Thomas
Thaddeus P. Thomas
JLJeffrey L. Langston
Jeffrey L. Langston
TMTodd M. Myers
Todd M. Myers
TSTsung-Ming Shih
Tsung-Ming Shih

1 August 2018 in Computational Biology and Chemistry
Verified
Journal Article
Closed access
ABAriana Beste
Ariana Beste
DTDeCarlos E. Taylor
DeCarlos E. Taylor
TSTsung-Ming Shih
Tsung-Ming Shih
TTThaddeus P. Thomas
Thaddeus P. Thomas